Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1374784 | Bioorganic & Medicinal Chemistry Letters | 2008 | 4 Pages |
Abstract
N-((8-Hydroxy-5-substituted-quinolin-7-yl)(phenyl)methyl)-2-phenyloxy/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2) have been prepared. Selected compounds 10, 14, 25, and 53 show sub-μM ADAMTS-5 potency and good selectivity over the related metalloproteases ADAMTS-4 (Aggrecanase-1), MMP-13, and MMP-12. Compound 53 shows a good balance of potent ADAMTS-5 inhibition, moderate CYP3A4 inhibition and good rat liver microsome stability. This series of compounds represents progress towards selective ADAMTS-5 inhibitors as disease modifying osteoarthritis agents.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Adam M. Gilbert, Matthew G. Bursavich, Sabrina Lombardi, Katy E. Georgiadis, Erica Reifenberg, Carl R. Flannery, Elisabeth A. Morris,